BSG and hepatocellular carcinoma: To further validate CD147 as an effective and valid target for HCC, we examined the cytotoxicity of CD147-CAR-T cells against two different HCC cell lines—HepG2 (Supplementary Fig. 9A) and SK-Hep1 (Supplementary Fig. 9B), using the FFLuc reporter assays.